Role of X-linked Inhibitor of Apoptosis Protein as Cancer Biomarker

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 12

Abstract

X-linked Inhibitor of Apoptosis Protein (XIAP), is one of the most important apoptotic inhibitors that plays a vital role in regulating various aspects of cell functions including cell cycle progression, arrest, and apoptosis. It is one of the most potent and widely studied members of the Inhibitors of Apoptosis Protein (IAP) family which promotes cell survival by inhibiting both extrinsic and intrinsic pathway of apoptosis depending on its intracellular concentration. It blocks major molecules (caspases-3, 7 and 9) which leads to the apoptosome formation responsible for cell death by neutralising caspases-3, 7 and caspase-9, through BIR3 and BIR2 domain respectively. As XIAP has a dominant contribution in the suppression of apoptosis in cancer cells and promotes cell growth, it plays an important role in development of various types of cancers. Overexpression of this protein is directly correlated with the prognosis of different malignancies. The property of XIAP as an apoptosis inhibitor with overexpression in different cancers makes it a useful therapeutic target for cancer therapy especially in resistant tumours and is a focus of molecular and clinical research both in vitro and in vivo. This review summarizes current knowledge on differential roles of XIAP as a cancer biomarker in common malignancies, its role as a predictive and prognostic tool and therapeutic target for cancer therapy

Authors and Affiliations

Manoj Pandey, MANISHA Shrivastava, Shweta Mishra, Rashmi Bathri

Keywords

Related Articles

Clinical Evaluation of Efficacy and Performance of All-Poly Tibial FreedomĀ® Total Knee System for Treating Osteoarthritis Patients: Three-Year Follow Up Study

Introduction: Advancement in technology in terms of design and building materials has made Total Knee Replacement (TKR) a highly effective, safe, and predictable orthopedic procedure. Aim: To review the clinical outcomes...

Perforated Jejunal Diverticulitis: An Uncommon Cause of Abdominal Pain

ABSTRACT Diverticular disease of the jejunum is a rare entity. Most patients with small bowel diverticula are asymptomatic. Patients who develop symptoms generally report symptoms that reflect associated complications. T...

Comparison of Fentanyl and Nalbuphine as an Adjuvant to 0.5% Bupivacaine for Ultrasound Guided Supraclavicular Brachial Plexus Block

ABSTRACT Introduction: Supraclavicular brachial plexus block is a commonly used, reliable regional anaesthetic technique for surgery of the upper limb. An adjuvant such as fentanyl/Nalbuphine is used to prolong the effec...

A Review of Clinical Evaluation and Management of Delirium

ABSTRACT Delirium is a syndrome characterised by the acute onset, fluctuating course of disturbed consciousness and cognitive impairment. It is an important medical condition with poor outcomes. Delirium is still under-r...

Download PDF file
  • EP ID EP368120
  • DOI 10.7860/JCDR/2017/29896.11013
  • Views 74
  • Downloads 0

How To Cite

Manoj Pandey, MANISHA Shrivastava, Shweta Mishra, Rashmi Bathri (2017). Role of X-linked Inhibitor of Apoptosis Protein as Cancer Biomarker. Journal of Clinical and Diagnostic Research, 11(12), 1-5. https://europub.co.uk/articles/-A-368120